Patent · US Active

System and methods for the production of personalized drug products

US10189616B2 · kind B2 · utility

29Cited by
14References
36Claims
0Family size

Inventor

Key dates

Filing dateAug 15, 2011
Grant dateJan 29, 2019
Priority date
Expiry dateAug 15, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A system and method for determining an optimal combination drug product for a particular patient includes a processor that receives patient information and determines an optimal combination drug product based on the received information. A system which can provide information regarding predicted events or pathologies based on received patient information and guidance on subsequent steps to ameliorate, treat or intervent. A drug production device includes a plurality of drug containers, each of which are coupled to a drug dispensing channel. A controller controls the dispensing of drug through each channel, and a combination drug product is produced from the dispensed drugs. A combination drug product includes a plurality of discrete units of a first drug, and a plurality of discrete units of a second drug. A transdermal patch includes a plurality of drug compartments, each containing a quantity of drug product, and a controller for controlling the release of drugs from each compartment. Feedback loop elements can enable iterations to optimized personalized doses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.